Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Reporting Guideline for Observational Studies in Metabolomic Epidemiology: Explanation and Elaboration of the Strobe-MetEpi Checklist.

Research square·2026
Same author

Prioritising efficacy over convenience.

American journal of respiratory and critical care medicine·2026
Same author

Asthma exacerbation profile of benralizumab for severe eosinophilic asthma (the BenRex study): a multicentre, prospective cohort study.

The Lancet. Respiratory medicine·2026
Same author

Reply to Zhao et al.: Clarifying Structural - Functional Coupling by FeNO Status in VESTIGE.

American journal of respiratory and critical care medicine·2026
Same author

Astegolimab for COPD With Frequent Exacerbations: Pooled Analysis of the ALIENTO and ARNASA Trials.

American journal of respiratory and critical care medicine·2026
Same author

Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trials.

Lancet (London, England)·2026
Same journal

Evaluation and management of pulmonary nodules: state-of-the-art and future perspectives.

Expert opinion on medical diagnostics·2013
Same journal

Biomarkers in IgA nephropathy: relationship to pathogenetic hits.

Expert opinion on medical diagnostics·2013
Same journal

The molecular landscape of diffuse glioma and prospects for biomarker development.

Expert opinion on medical diagnostics·2013
Same journal

Difficulties and barriers in diagnosing Fabry disease: what can be learnt from the literature?

Expert opinion on medical diagnostics·2013
Same journal

Promising biomarkers for systemic lupus erythematosus.

Expert opinion on medical diagnostics·2013
Same journal

Challenges of COPD diagnosis.

Expert opinion on medical diagnostics·2013
See all related articles

Related Experiment Video

Updated: May 13, 2026

Multi-modal Pulmonary Imaging: Using Complementary Information from CT and Hyperpolarized 129Xe MRI to Evaluate Lung Structure-Function
02:09

Multi-modal Pulmonary Imaging: Using Complementary Information from CT and Hyperpolarized 129Xe MRI to Evaluate Lung Structure-Function

Published on: April 12, 2024

Imaging advances in asthma.

Carolina Walker1, Sumit Gupta, Vimal Raj

  • 1University of Leicester , Institute for Lung Health, Department of Infection , Inflammation and Immunity, Leicester , UK.

Expert Opinion on Medical Diagnostics
|March 15, 2013
PubMed
Summary
This summary is machine-generated.

Advanced imaging techniques offer new insights into severe asthma, aiding in understanding its complex nature and guiding future research for better patient outcomes. These methods are crucial for personalized treatment strategies.

More Related Videos

A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice
07:38

A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice

Published on: April 13, 2018

Related Experiment Videos

Last Updated: May 13, 2026

Multi-modal Pulmonary Imaging: Using Complementary Information from CT and Hyperpolarized 129Xe MRI to Evaluate Lung Structure-Function
02:09

Multi-modal Pulmonary Imaging: Using Complementary Information from CT and Hyperpolarized 129Xe MRI to Evaluate Lung Structure-Function

Published on: April 12, 2024

A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice
07:38

A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice

Published on: April 13, 2018

Area of Science:

  • Pulmonary Medicine
  • Medical Imaging

Background:

  • Severe asthma affects 5-10% of adults globally, presenting a significant health challenge with high morbidity and mortality.
  • Recent advancements in non-invasive imaging technologies allow for comprehensive functional assessment of the lungs.

Purpose of the Study:

  • To review technological advances in imaging for severe asthma.
  • To explore the potential of these technologies in understanding asthma pathophysiology and structure-function relationships.

Main Methods:

  • Chronological review of current and future imaging technologies.
  • Discussion of imaging modalities including X-rays, CT, MRI, confocal fluorescence endomicroscopy, and computational fluid dynamics.
  • Identification of pitfalls in airway and lung parenchyma imaging for asthma.

Main Results:

  • Novel imaging techniques provide detailed analysis of airway architecture and small airway structure.
  • Functional and physiological evaluations are now possible with advanced imaging modalities.
  • Imaging advances enhance understanding of severe asthma pathophysiology.

Conclusions:

  • Despite progress, validation through clinical trials is needed to correlate imaging measures with clinical outcomes.
  • Imaging holds potential for identifying new severe asthma phenotypes and predicting treatment response.
  • Further research is crucial to unravel the structure-function relationship in severe asthma.